Add Yahoo as a preferred source to see more of our stories on Google. A nasal spray version of esketamine was more effective for depression that is resistant to treatment than a more commonly used ...

This week, the FDA approved esketamine, the first nasal spray to treat depression in adults who have tried other antidepressant medications without success. Esketamine, which the FDA approved to be ...

Key opportunities in the esketamine market include addressing the rising prevalence of treatment-resistant depression with ...

Ketamine has a long and varied past as a pharmaceutical. It was developed in 1962, tested on subjects in 1964 and approved as an anesthetic in 1970 in the United States. Ketamine was used in the ...

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in patients with depressive episodes that didn’t respond to ...

Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Champalimaud Foundation’s Neuropsychiatry Unit and the ...

Please provide your email address to receive an email when new articles are posted on . Depressive symptoms improved within 24 hours of the first dose of esketamine nasal spray. Common adverse effects ...

The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson & ...

BARCELONA — Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca), an atypical antipsychotic, for treatment-resistant depression (TRD), results ...

Please provide your email address to receive an email when new articles are posted on . If this indication of esketamine is approved, it would be the first monotherapy for treatment-resistant ...

In a recent study published in the British Medical Journal, researchers investigated whether low-dose esketamine delivered after labor improves post-delivery depression in women with prenatal ...